A randomized trial of weekly high-dose calcitriol and weight-bearing exercise for cancer treatment–induced bone loss (CTIBL) and bone metabolism in ER+ breast cancer (BC) patients

Authors :: R. N. Rosier
Luke J. Peppone
Gary R. Morrow
Oxana Palesh
Jason Q. Purnell
Michelle C. Janelsins
Lisa K. Sprod
Alissa Huston
Marilyn N. Ling
Karen M. Mustian
Source :: Journal of Clinical Oncology. 28:9100-9100
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: 9100 Background: CTIBL is a long-term side effect of hormone therapy (HT) and occurs in up to 80% of women being treated for BC. Daily calcitriol (active vitamin D) therapy improves bone metabolism...

Full Text Access

Tools